Gliomas of CDNP-R848 treated mice depicted an altered T cell composition with increased CD4+ T cell proliferation and decreased Lag3-mediated T cell exhaustion, likely driven by IL-12 upregulation. This evidence concerns the gene CD4 and glioma.